Nutra Pharma Corporation , a biotechnology company that is developing treatments for Multiple Sclerosis , Human Immunodeficiency Virus , Adrenomyeloneuropathy and Pain, announced today that the Company has entered into a licensing agreement with Cobra Pharmaceuticals for the re-launch of their all-natural, non-addictive pain reliever - Cobroxin , ... (more)
http://www.freshnews.com/news/809010/nutra-pharma-announces-licensing-agreement-marketing-and-distribution-its-all-natural-p
http://www.freshnews.com/news/809010/nutra-pharma-announces-licensing-agreement-marketing-and-distribution-its-all-natural-p
No comments:
Post a Comment